Based in Seoul, South Korea, GeneOne Life Science Inc. is a global leader in the field of gene-based biomedicine. The company focuses on developing and manufacturing DNA vaccines and products to prevent and treat incurable diseases. With its wholly-owned manufacturing subsidiary, VGXI, Inc., located in Texas, GeneOne Life Science Inc. collaborates with global companies and institutions to conduct pre-clinical and clinical trials. Recently, the company has partnered with Houston Methodist researchers to develop an RNA vaccine against COVID-19. In addition to COVID-19, GeneOne Life Science Inc. also works on vaccines for pandemic influenza, seasonal influenza, chronic hepatitis B and C, as well as cancers and other infectious diseases.